ITIH5 and cancer: We found that, apart from ITIH5, ITIH1-ITIH4 were all robustly expressed in liver hepatocellular carcinoma (LIHC) and cholangio carcinoma (CHOL), with no or low expression in other cancer types (Figure 2).